We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Graft Polymer (uk) Plc | LSE:GPL | London | Ordinary Share | GB00BMD1Z199 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.145 | 0.14 | 0.15 | 0.145 | 0.145 | 0.15 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 542k | -2.71M | -0.0260 | -0.05 | 145.74k |
Date | Subject | Author | Discuss |
---|---|---|---|
14/5/2024 10:46 | It actually stands half a chance now that Zomer is no longer involved. | flc | |
09/5/2024 08:12 | Fund raise on the way as they need to raise, question is at what price in these dire markets as many recent raises have been at big discounts | pre | |
02/5/2024 11:11 | Think I may have stumbled across an extremely interesting minnow here. Following the RNS put out this morning announcing the appointment of Anthony Tennyson as the new CEO there could be very exciting times ahead. His CV looks exceptional and has also a background in finance having worked at Merrill Lynch and Bank of Ireland both blue chip names. Besides that his career has been in Life Sciences and this is exactly what this company needs. With such a tiny market cap there is huge potential upside here. | highlyregal | |
01/5/2024 09:23 | Direction with new investors - Graft Bio division continues to see ongoing interest and the potential demand we are witnessing provides encouraging possibilities for the future. We anticipate that this may position the Company as a multi-sector specialist chemical firm offering expertise and R&D capabilities to develop high-end solutions for refiners, compounders and processors, rather than solely producing them in-house. Focus now on this division | tomboyb | |
29/4/2024 12:37 | RNS indicating new investors have stuck another 3100k in - | tomboyb | |
15/4/2024 11:35 | 135k market cap - ? | tomboyb | |
15/3/2024 12:09 | market cap £166K is that all it takes nowadays to get listed | the bull | |
15/3/2024 10:56 | https://www.linkedin | mally6 | |
27/12/2023 09:51 | I warned you all another Roby Scam . | goforgold1 | |
22/12/2023 08:02 | Nowhere by the looks of it! | flc | |
09/10/2023 08:08 | Yet another load of tosh...where is the money? | flc | |
27/9/2023 08:03 | Beware, this is following the same pattern as MXC...lots of new contracts, no cash and constant fund raises, | flc | |
26/9/2023 15:08 | Looks like MGC are in trouble Roby Zomer looks like he'll be taking it private. | hatfullofsky | |
21/9/2023 10:55 | Gofor, I'm not convinced it's a fraud but the Concert party does worry me, main shareholders and directors own 60% so they can basically do what they want, sell, take it private etc but I think they benefit from a full LSE not AIM listingRoby Zomer is Founder and CEO of MGC Pharma but only holds 1% - Premier own 10%)Get the orders in and the revenue, large order book the raise and dilute the Concert to under 40% | hatfullofsky | |
05/9/2023 09:43 | Just looking in, as the chart seems very interesting. However from my quick look it seems a bit like a 'jam tomorrow' company?Is this an Israeli company? | cyberbub | |
30/8/2023 08:12 | Another supply agreement. That's the 2nd one in 7 days. Shares are definitely worth much more than their price. | z1co | |
24/8/2023 15:15 | Do a company search on this scumbag . Notice the area were the number comes from same as deals ..MGC Pharmaceuticals Ltd Roby Zomer CEO & Managing Director +61 8 6382 3390 info@mgcpharma.com.a | goforgold1 | |
24/8/2023 07:52 | There were plenty of figures in that rns but understand your cautioun. For the mcap I believe it's "cheap" but who knows. Time will tell. | babbler | |
23/8/2023 10:05 | Babbler...I don't totally agree with all of GFG1's comments but there is a complex network behind the scenes here and I would advise any investors to tread carefully and DTOR. There's always lots of good news flow but limited info on figures and they do like to raise cash at fairly regular intervals. | flc |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions